dextrothyroxine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaal, AA; Afife, AA; Badawi, MA; Fadl, HO; Fahmy, MA; Hassan, SI; Ismail, MAM; Khairy, RA; Shalaby, MA | 1 |
| Feng, X; Inaba, Y; Jin, L; Li, S; Li, Y; Lin, S; Liu, H; Pan, Z; Qiu, L; Rong, H; Wang, R; Wang, S; Wang, Z; Xie, W; Zheng, W | 1 |
2 other study(ies) available for dextrothyroxine and Alloxan Diabetes
| Article | Year |
|---|---|
Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium; Diabetes Mellitus, Experimental; Ivermectin; Mice; Nitro Compounds; Rodent Diseases; Selenium; Thiazoles | 2021 |
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism.
Topics: Animals; Antiparasitic Agents; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Experimental; Diet, High-Fat; Humans; Hyperglycemia; Hyperlipidemias; Ivermectin; Ligands; Metabolism; Mice; Mice, Knockout; Models, Molecular; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear | 2013 |